Cargando…

Long-term methotrexate efficacy in juvenile localized scleroderma

Detalles Bibliográficos
Autores principales:	Zulian, F, Vallongo, C, Vittadello, F, Zanon, G, Giuliotto, S, Martini, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194410/ http://dx.doi.org/10.1186/1546-0096-9-S1-O16

Ejemplares similares

Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma
por: Martini, Giorgia, et al.
Publicado: (2020)

PReS-FINAL-2120: Juvenile scleroderma international network (JUSINET) database: a reliable instrument for clinical research in juvenile scleroderma syndromes
por: Cuffaro, G, et al.
Publicado: (2013)

Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
por: Martini, G, et al.
Publicado: (2008)

PReS-FINAL-2128: Quality of life and psychosocial aspects in juvenile localized scleroderma (JLS): a cross-sectional study in 40 patients
por: Culpo, R, et al.
Publicado: (2013)

Efficacy and safety of methotrexate treatment of juvenile localized scleroderma
por: Osminina, MK, et al.
Publicado: (2008)

YIM-O20. Standardization and performance of cone beam ct scan for the evaluation of linear scleroderma of the face
por: Di Giovanni, Chiara, et al.
Publicado: (2014)

Reliability of LoSCAT score for activity and tissue damage assessment in a large cohort of patients with Juvenile Localized Scleroderma
por: Agazzi, Anna, et al.
Publicado: (2018)

PReS13-SPK-1469: Juvenile scleroderma
por: Zulian, F
Publicado: (2013)

Connective tissue nevus misdiagnosed as juvenile localized scleroderma
por: Tirelli, F., et al.
Publicado: (2023)

13.4 High frequency of CNS involvement in linear scleroderma of the face
por: Parolin, M, et al.
Publicado: (2008)

2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatment extension
por: Ruperto, N, et al.
Publicado: (2008)

Complementary and alternative medicine (CAM) in pediatric rheumatology: an European perspective
por: Fadanelli, G, et al.
Publicado: (2011)

PReS-FINAL-2004: Musculoskeletal pain in schoolchildren across puberty: a 3-year follow-up study
por: Sperotto, F, et al.
Publicado: (2013)

Cone beam computed tomography for the assessment of linear scleroderma of the face
por: Di Giovanni, C., et al.
Publicado: (2018)

Tonsillectomy efficacy is comparable to the standard medical treatment in PFAPA syndrome
por: Vigo, G, et al.
Publicado: (2011)

PReS-FINAL-2184: A randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate
por: Ruperto, N, et al.
Publicado: (2013)

The prospective juvenile systemic sclerosis inceptions cohort – http://www.juvenile-scleroderma.com
por: Foeldvari, I, et al.
Publicado: (2008)

12.3 Long-term follow up of patients with CINCA syndrome: efficacy and tolerability of Anakinra treatment
por: Paloni, G, et al.
Publicado: (2008)

Long-term efficacy and safety of adalimumab in 4-12 year old patients with juvenile idiopathic arthritis
por: Ruperto, N, et al.
Publicado: (2011)

PReS-FINAL-2360: Severe disease course of pediatric-onset granulomatosis with polyangiitis as compared to adult patients: a long-term, single center, follow up study
por: Minardo, G, et al.
Publicado: (2013)

Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever
por: Horneff, G, et al.
Publicado: (2015)

8.5 Predictors of long-term outcome of Juvenile Dermatomyositis (JDM): a Multicenter, Multinational Study of 490 patients
por: Ferrari, C, et al.
Publicado: (2008)

Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis
por: Van Dijkhuizen, Pieter E H, et al.
Publicado: (2011)

Strategic use of levofolinic acid for methotrexate-induced side effects in juvenile idiopathic arthritis: a prospective observational study
por: Martini, Giorgia, et al.
Publicado: (2023)

Juvenile localized scleroderma: review of 44 patients
por: Iglesias, E, et al.
Publicado: (2011)

SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile localized scleroderma and juvenile systemic sclerosis
por: Culpo, Roberta, et al.
Publicado: (2014)

2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)
por: Yokota, S, et al.
Publicado: (2008)

Extracranial linear localized scleroderma associated with longstanding epileptic encephalopathy unresponding to methotrexate and prednisone
por: Rigante, D, et al.
Publicado: (2008)

Unexplained recurrent arthritis as presenting sign of hereditary autoinflammatory syndromes
por: Zulian, F, et al.
Publicado: (2011)

Localized scleroderma in a cohort of juvenile idiopathic arthritis children
por: Giani, Teresa, et al.
Publicado: (2014)

Infectious agents in juvenile scleroderma
por: Chyzheuskaya, Iryna, et al.
Publicado: (2014)

Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (sJIA): TENDER 52-week data
por: De Benedetti, Fabrizio, et al.
Publicado: (2012)

7.4 Improvements in individual disease components are sustained with long-term adalimumab therapy for polyarticular Juvenile Idiopathic Arthritis
por: Ruperto, N, et al.
Publicado: (2008)

OA16 A great imitator of scleroderma
por: Josè, Alexa, et al.
Publicado: (2022)

The frequency of pulmonary hypertension in juvenile scleroderma
por: Adrovic, Amra, et al.
Publicado: (2014)

3.5 Comparison of functional ability in juvenile idiopathic arthritis, juvenile dermatomyositis, juvenile systemic lupus erythematosus and healthy controls. An analysis of the PRINTO database
por: Filocamo, G, et al.
Publicado: (2008)

Study about evaluation of efficacy of methotrexate in localized scleroderma using ultrasonography
por: Zhang, Fan, et al.
Publicado: (2023)

7.5 Safety data from over 1,200 patients-years of methotrexate and/or etanercept treatment in children with polyarticular or systemic juvenile rheumatoid arthritis
por: Giannini, EH, et al.
Publicado: (2008)

No benefit of the combination therapy etanercept and methotrexate compared to etanercept mono therapy in juvenile idiopathic arthritis – a matched pair analysis
por: Schmeling, Heinrike, et al.
Publicado: (2012)

Reliability of using an ultrasound scoring measure for juvenile localized scleroderma (jLS)
por: Li, Suzanne C, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qeb1fr8umd1l0vi3mgel317mr2